Abstract

BackgroundPatients with chronic inflammatory disorders such as inflammatory bowel disease frequently experience neurological complications including epilepsy, depression, attention deficit disorders, migraines, and dementia. However, the mechanistic basis for these associations is unknown. Given that many patients are unresponsive to existing medications or experience debilitating side effects, novel therapeutics that target the underlying pathophysiology of these conditions are urgently needed.MethodsBecause intestinal disorders such as inflammatory bowel disease are robustly associated with neurological symptoms, we used three different mouse models of colitis to investigate the impact of peripheral inflammatory disease on the brain. We assessed neuronal hyperexcitability, which is associated with many neurological symptoms, by measuring seizure threshold in healthy and colitic mice. We profiled the neuroinflammatory phenotype of colitic mice and used depletion and neutralization assays to identify the specific mediators responsible for colitis-induced neuronal hyperexcitability. To determine whether our findings in murine models overlapped with a human phenotype, we performed gene expression profiling, pathway analysis, and deconvolution on microarray data from hyperexcitable human brain tissue from patients with epilepsy.ResultsWe observed that murine colitis induces neuroinflammation characterized by increased pro-inflammatory cytokine production, decreased tight junction protein expression, and infiltration of monocytes and neutrophils into the brain. We also observed sustained neuronal hyperexcitability in colitic mice. Colitis-induced neuronal hyperexcitability was ameliorated by neutrophil depletion or TNFα blockade. Gene expression profiling of hyperexcitable brain tissue resected from patients with epilepsy also revealed a remarkably similar pathology to that seen in the brains of colitic mice, including neutrophil infiltration and high TNFα expression.ConclusionsOur results reveal neutrophils and TNFα as central regulators of neuronal hyperexcitability of diverse etiology. Thus, there is a strong rationale for evaluating anti-inflammatory agents, including clinically approved TNFα inhibitors, for the treatment of neurological and psychiatric symptoms present in, and potentially independent of, a diagnosed inflammatory disorder.

Highlights

  • Patients with chronic inflammatory disorders such as inflammatory bowel disease frequently experience neurological complications including epilepsy, depression, attention deficit disorders, migraines, and dementia

  • Our experiments show that neuroinflammation and neuronal hyperexcitability develop in all three colitis models as a consequence of TNFα-secreting neutrophils that infiltrate the brain

  • Flurothyl was chosen for these experiments for three reasons: (1) it is administered via inhalation, which allows for control of dosing and limits mortality; (2) it is not metabolized and has no known direct influences on the immune response; and (3) unlike transgenic spontaneous seizure models, confounding effects of genetic mutations on immune responses and seizure-induced inflammation are avoided

Read more

Summary

Introduction

Patients with chronic inflammatory disorders such as inflammatory bowel disease frequently experience neurological complications including epilepsy, depression, attention deficit disorders, migraines, and dementia. Patients with chronic inflammatory conditions frequently experience neurological and psychiatric complications including epilepsy, depression, attention deficit and hyperactivity disorders, migraines, and dementia [1,2,3,4,5,6,7]. Psychiatric and neurological medications frequently produce disruptive and debilitating side effects such as cognitive impairment, sedation, exacerbation of other neurological and psychiatric symptoms, and sexual dysfunction [9, 10] These severe side effects combined with the large number of patients who do not respond to existing therapies provide a strong rationale to examine the mechanistic connection between peripheral inflammation and the development of neurological symptoms. Given that 4.5% of Americans suffer from an autoinflammatory disease [11], strategies to protect this population from developing neurological complications, as well as treat them, are urgently needed

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call